Patients experience symptoms and have detectable changes in blood and other biomarkers in the time prior to their cancer diagnosis, thereby creating a time window in which imaging or biomarker testing may facilitate timely diagnosis. The overriding research theme of this unit is to evaluate pathways to diagnosis of cancer at an earlier and more treatable stage, both symptomatically and by screening. We achieve this by a combination of clinical and behavioural studies in community, primary and secondary care settings and within the existing NHS Cancer Screening Programmes in the UK. We hold major programme funding for these activities from the Department of Health and Social Care (via the National Institute for Health Research and Policy), Cancer Research UK, and Barts Charity. We also lead an NIHR Global Health Group advancing early diagnosis of cancer in South Africa.
OUR TEAMProf. Stephen Duffy
Dr. Samantha Quaife
Prof. Fiona Walter
Dr. Grace Okoli
Prof. Suzanne Scott
Dr. Oleg Blyuss
Prof. Georgia Black
Dr. Judith Offman
CONTACT
Charterhouse Square
Naomi Turnbull, n.turnbull@qmul.ac.uk